Can't find what you're looking for?
View all search resultsCan't find what you're looking for?
View all search resultshe Food and Drug Monitoring Agency (BPOM) has asserted that an Indomie instant noodle variant that has been pulled from shelves in Taiwan and Malaysia for containing carcinogens, is in fact safe for consumption.
The BPOM said on Thursday that while the Indomie chicken special variant did contain ethylene oxide, the carcinogen was present at levels that were acceptable by the agency’s standards.
The BPOM said food products manufactured in Indonesia were permitted to contain up to 85 parts per million (ppm) of ethylene oxide.
"The level detected in the instant noodle sample in Taiwan (0.34 ppm) is still way below the standard applied in Indonesia and in other countries like the United States and Canada," the agency said.
The BPOM added that it understood why authorities in Taiwan had banned the sale of Indomie chicken special, as ethylene oxide was prohibited in food products there.
"In Indonesia, the instant noodle is safe for consumption as it has complied with the standard applied here," the agency contended.
Earlier this week, the Taipei Health Department detected the carcinogen in at least one Indomie instant noodle variant from Indonesia, following a random inspection of various brands of instant noodles available in the city.
Share your experiences, suggestions, and any issues you've encountered on The Jakarta Post. We're here to listen.
Thank you for sharing your thoughts. We appreciate your feedback.
Quickly share this news with your network—keep everyone informed with just a single click!
Share the best of The Jakarta Post with friends, family, or colleagues. As a subscriber, you can gift 3 to 5 articles each month that anyone can read—no subscription needed!
Get the best experience—faster access, exclusive features, and a seamless way to stay updated.